Curves International   Report issue

For profit
Founded: Harlingen Texas United States (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2009
NCT04344821
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Curves International

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 6